Bill to Lower Prescription Drug Prices

What This Bill Does

This bill would establish fairer prices for prescription drugs, aiming to reduce what Americans pay at the pharmacy. It has been referred to the House committees with jurisdiction over health, legal, and financial issues for further review.

If enacted, the bill could lower out-of-pocket drug costs for patients, improve access to needed medications, and reduce pressure on family budgets, insurers, and public health programs. It would be especially important for people who take brand-name or specialty drugs regularly.

Who This Bill Affects

For the general public, this bill could mean lower prescription costs and better access to medications, especially for people with chronic conditions or high drug expenses. It could also affect insurers, pharmacies, and drug manufacturers through pricing and reimbursement changes.

Latest Status

May 26, 2026

Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.